193 related articles for article (PubMed ID: 38789199)
1. Updates in Translational Science for Esophageal and Gastric Cancers.
Hompe ED; Sachdeva UM
Surg Oncol Clin N Am; 2024 Jul; 33(3):571-581. PubMed ID: 38789199
[TBL] [Abstract][Full Text] [Related]
2. Tumor organoids to study gastroesophageal cancer: a primer.
Jin RU; Mills JC
J Mol Cell Biol; 2020 Aug; 12(8):593-606. PubMed ID: 32652008
[TBL] [Abstract][Full Text] [Related]
3. Progress and perspective of organoid technology in cancer-related translational medicine.
Lin Y; Jiang L; He Q; Yuan M; Cao J
Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
[TBL] [Abstract][Full Text] [Related]
4. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
5. Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.
Sachdeva UM; Shimonosono M; Flashner S; Cruz-Acuña R; Gabre JT; Nakagawa H
Cancer Lett; 2021 Jul; 509():39-52. PubMed ID: 33838281
[TBL] [Abstract][Full Text] [Related]
6. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
Yuan J; Li X; Yu S
Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
[TBL] [Abstract][Full Text] [Related]
7. Organoids: approaches and utility in cancer research.
Zhou B; Feng Z; Xu J; Xie J
Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques.
Abd El-Salam MA; Troulis MJ; Pan CX; Rao RA
Cancer Cytopathol; 2024 Feb; 132(2):96-102. PubMed ID: 37843532
[TBL] [Abstract][Full Text] [Related]
9. The Molecular Biologic Basis of Esophageal and Gastric Cancers.
Pennathur A; Godfrey TE; Luketich JD
Surg Clin North Am; 2019 Jun; 99(3):403-418. PubMed ID: 31047032
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer.
Zeng Y; Jin RU
Semin Cancer Biol; 2022 Nov; 86(Pt 3):566-582. PubMed ID: 34933124
[TBL] [Abstract][Full Text] [Related]
11. Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine.
Seidlitz T; Koo BK; Stange DE
Cell Death Differ; 2021 Jan; 28(1):68-83. PubMed ID: 33223522
[TBL] [Abstract][Full Text] [Related]
12. Cancer research using organoid technology.
Kretzschmar K
J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
[TBL] [Abstract][Full Text] [Related]
13. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
Jung JO; Nienhüser H; Schleussner N; Schmidt T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023907
[TBL] [Abstract][Full Text] [Related]
14. Organoids: Construction and Application in Gastric Cancer.
Huo C; Zhang X; Gu Y; Wang D; Zhang S; Liu T; Li Y; He W
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238742
[TBL] [Abstract][Full Text] [Related]
15. Xenograft and organoid models in developing precision medicine for gastric cancer (Review).
Xu J; Yu B; Wang F; Yang J
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38390969
[TBL] [Abstract][Full Text] [Related]
16. Gastric Organoids: Progress and Remaining Challenges.
Pang MJ; Burclaff JR; Jin R; Adkins-Threats M; Osaki LH; Han Y; Mills JC; Miao ZF; Wang ZN
Cell Mol Gastroenterol Hepatol; 2022; 13(1):19-33. PubMed ID: 34547535
[TBL] [Abstract][Full Text] [Related]
17. Cancer modeling meets human organoid technology.
Tuveson D; Clevers H
Science; 2019 Jun; 364(6444):952-955. PubMed ID: 31171691
[TBL] [Abstract][Full Text] [Related]
18. Organoid Models of Tumor Immunology.
Yuki K; Cheng N; Nakano M; Kuo CJ
Trends Immunol; 2020 Aug; 41(8):652-664. PubMed ID: 32654925
[TBL] [Abstract][Full Text] [Related]
19. Translational models of 3-D organoids and cancer stem cells in gastric cancer research.
Wuputra K; Ku CC; Kato K; Wu DC; Saito S; Yokoyama KK
Stem Cell Res Ther; 2021 Sep; 12(1):492. PubMed ID: 34488885
[TBL] [Abstract][Full Text] [Related]
20. Immune organoids: from tumor modeling to precision oncology.
Dao V; Yuki K; Lo YH; Nakano M; Kuo CJ
Trends Cancer; 2022 Oct; 8(10):870-880. PubMed ID: 35773148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
